The Advocate General of the Court of Justice of the European Union has given a fresh interpretation to restrictions laid down by the court in 2011 on the patentability of human embryos for industrial or commercial purposes. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News IPR & Legal
